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Two unique polypeptides, 22.4 and 16.4 kDa, were
prominent in some human cataracts. Both proteins were
identified as modified forms of the small heat shock
protein, aB-crystallin. The concentration of total aB-
crystallin in most of these cataracts was significantly
increased. The 22.4-kDa protein was subsequently des-
ignated as aBg. Mass spectrometric analyses of tryptic
and Asp-N digests showed aBg is aB-crystallin minus the
C-terminal lysine. aBg constituted 10–90% of the total
aB-crystallin in these cataracts and was preferentially
phosphorylated over the typical form of aB-crystallin.
Human aBg and aB-crystallin were cloned and ex-
pressed in Escherichia coli. The differences in electro-
phoretic mobility and the large difference in native pI
values suggest some structural differences exist. The
chaperone-like activity of recombinant human aBg was
comparable to that of recombinant human aB-crystallin
in preventing the aggregation of lactalbumin induced
by dithiothreitol. The mechanism involved in generat-
ing aBg is not known, but a premature termination of
the aB-crystallin gene was ruled out by sequencing the
polymerase chain reaction products of the last exon for
the aB-crystallin gene from lenses containing aBg. The
16.4-kDa protein was an N-terminally truncated frag-
ment of aBg. The high concentration of aB-crystallin in
these cataracts is the first observation of this kind in
human lenses.
The three major classes of mammalian crystallins, a-, b-, and
g-crystallins, constitute about 90% of the total protein in the
eye lens and are considered to determine the refractive prop-
erties of the lens. Post-translational modification of the crys-
tallins has been a major focus of the research in trying to
elucidate causes for the loss of lens transparency or cataract
development (1–4). a-Crystallins have received the most atten-
tion in this case. The two homologous subunits, aA- and aB-
crystallin, make up about 30% of the proteins in young human
lenses and in the outer cortex of the adult human lens. aB-
crystallin is a normal constituent of most mammalian tissues
but is present in the highest concentrations in lens (5, 6). In
addition to the lens, aA-crystallin is found in spleen and thy-
mus (7). a-Crystallins are present in fiber cell extracts as large
heteroaggregates with apparent molecular masses reported
from 300 to 1000 kDa (8, 9). In cataracts the sizes of the
aggregates reportedly increase and these aggregates are
thought to be responsible for the light scattering (2).
On the other hand, a-crystallins are members of the family of
small heat shock proteins and are thought to provide protection
against cellular stresses (10–12). Members of this family are
structurally related via the a-crystallin domain, they form
large aggregates, are phospho-proteins, and have chaperone-
like activity (12–19). a- Crystallins prevent the aggregation of
proteins induced by heat, oxidation, or chemicals. In cultured
cells, expression of aB-crystallin is induced by heat shock,
oxidative stress, osmotic stress, arsenite, phorbol 12-myristate
13-acetate, and hormones such as estrogen and dexamethasone
(20–23). Thus, the role of aB-crystallin in many systems is
considered to be that of a stress protein. In the lens, however,
it is not known whether the primary function of aB-crystallin is
that of a stress protein and related to its chaperone-like func-
tion or if its major role is structural. It is possible its role in the
lens may change depending on the stage of development and
location in the lens.
Both a-crystallins undergo post-translational modifications
including truncation of both N and C termini, deamidation,
racemization, phosphorylation, methionine oxidation, glyca-
tion, disulfide formation, addition of O-GlcNAc, and the addi-
tion of 72 mass units to the C-terminal lysine of aB-crystallin
(4, 17–19, 24, 25). Some of these such as phosphorylation and
specific cleavage may be important functionally, others are
likely the result of aging and detrimental stresses. Any of these
modifications are likely to alter the protein conformation which
in turn could alter the aggregate size and/or the function of a-
crystallin in the cell.
Two-dimensional electrophoresis of tissue proteins is the
major technique used to detect post-translationally modified
proteins in cell and tissue extracts. We have used this tech-
nique extensively in an attempt to identify changes in the
concentration or modification of lens proteins that could be
unique to developmental, aging, and cataractogenic processes.
In this study we report the identification and characteriza-
tion of two unique polypeptides observed on two-dimensional
gel electrophoresis of human cataracts. One of the proteins was
present in high concentration comparable to the concentration
of a crystallin. Both are likely the result of stress-induced
processes on the path to cataract formation.
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MATERIALS AND METHODS
Normal Lenses and Cataracts—Normal human lenses were obtained
from the National Disease Research Interchange, Philadelphia, PA.
Human cataractous material was obtained from intracapsular cataract
surgery done in India and from extracapsular extractions done at the
National Eye Institute. Tenets of the Declaration of Helsinki for dealing
with human samples were strictly followed. The lens capsule epithelia
were removed, and the lenses were separated into the lens cortical and
nuclear regions as described previously (26).
Two-dimensional Gel Electrophoresis—A proteinase inhibitor mix-
ture containing 4-(2-aminoethyl)-benzenesulfonyl fluoride, pepstatin A,
trans-epoxysuccinyl-L-leucylamido(4-guanidino)butane (E-64), besta-
tin, leupeptin, and aprotinin (Sigma) was added to frozen lens cortex
samples. The samples were thawed and homogenized in 9 M urea, 2 or
4% Nonidet P-40, 10 mM DTT,1 2% Resolyte 3.5–10. Two-dimensional
gel electrophoresis was done according to previously described proce-
dures (27, 28). Non-linear, pH 3–10, 18-cm dry strips (Amersham Phar-
macia Biotech) were used. Samples were loaded onto the acidic end and
focused for 32,000 V-h. The strips were then frozen at least 1 h and
equilibrated twice, first in 50 mM Tris, pH 6.8, containing 6 M urea, 1%
SDS, with 1% DTT and then in the same buffer mix but with 4.5%
iodoacetamide. The second dimension was done in the Iso-Dalt Gel
Electrophoresis System using 15–18% gradient gels. Molecular weight
markers (Bio-Rad) and pI markers (carbamylated CPK, BDH Labora-
tory Supplies) were included. Proteins were stained with colloidal Coo-
massie Blue G-250 or with PhastGel BlueR (Amersham Pharmacia
Biotech) when protein spots were analyzed by mass spectrometry. Gels
were scanned using a Molecular Dynamics Personal Densitometer, and
protein spots were quantified using ImageQuant software.
Protein Sequencing and Immunoreactivity—Proteins were electro-
phoretically transferred from the two-dimensional gels to polyvinyli-
dene difluoride membranes (Millipore). Tryptic peptide maps and Ed-
man sequencing were done by Harvard MicroChem. Immunoreactivity
was determined using Tropix Western-Light detection kit (PE Applied
BioSystems).
Mass Spectrometry—Proteins were subjected to in-gel digestion with
either trypsin (Promega) or Asp-N endoproteinase (Wako) as described
previously (29). Extracted peptides were spotted with a-cyano-4-hy-
droxycinnamic acid and analyzed using a PE Biosystems Voyager DE
STR matrix-assisted laser desorption-time of flight (MALDI-TOF) mass
spectrometer. Data were processed using GRAMS/386 software.
Cloning of aB-crystallin and aBg—RNA was obtained from a 16-
year-old human lens. The isolation was done by combining the guani-
dine isothiocyanate lysis with the silica gel membrane technology using
the Qiagen RNeasy kit. Oligo(dT)-primed cDNA was prepared from
total RNA using the Amersham Pharmacia Biotech T-primed first
strand kit. The coding regions of human aB-crystallin and aBg were
amplified by PCR using primers containing NcoI or HindIII sites and
were inserted into the cloning vector pCR2.1-TOPO (Invitrogen, San
Diego, CA). In the PCR reactions the following primer (forward), which
corresponds to the 59 end of the coding region of human aB-crystallin,
was used for both aB-crystallin and aBg: 59-TAAGAAGGAGATATAC-
CATGGACATCGCCA-39. The reverse primers used for human aB-crys-
tallin and aBg were 59-CAAAAGCTTATTACTATTTCTTGGGGGCT-
G-39 and 59-GGCCGCAAGCTTTCACTTGGGGGCTG-39, respectively.
The latter will terminate the coding sequence after Lys174. The under-
lined nucleotides indicate the restriction sites. The clones were propa-
gated in Escherichia coli DH5 aTM (Life Technologies Inc.). The coding
region of these constructs were confirmed by DNA sequence analysis
using the dye terminator cycle sequencing method (PE Applied Biosys-
tems, Warrington, UK).
Construction of Expression Vectors—The coding region of human
aB-crystallin and aBg were removed from the cloning vector by double
digestion with NcoI and HindIII restriction enzymes and ligated into
NcoI-HindIII-cut pET-21d(1) (Novagen, Madison, WI). Recombinant
plasmids were identified by NcoI-HindIII digestion and amplification of
human aB-crystallin by PCR using internal primers.
Expression and Purification of Human aB-crystallin and aBg—Re-
combinant pET-21d(1)-HaBC and pET-21d(1)-HaBgC expression plas-
mids were used to transform competent E. coli BL21(DE3) cells (Strat-
agene, San Diego, CA). Transformants were grown at 37 °C in 1 liter of
Super Broth to A600 5 0.8. aB-crystallin and aBg expression were then
induced by addition of isopropyl-b-D-galactospyranoside to a final con-
centration of 1 mM and then the culture was incubated at 37 °C for 5 h.
Cells were collected by centrifugation at 3,000 3 g for 10 min at 4 °C
and resuspended in 25 ml of lysis buffer, 50 mM sodium phosphate
buffer, pH 7, containing 150 mM NaCl, 0.02% sodium azide, and a
protease inhibitor mix (Roche Molecular Biochemicals). Cells were dis-
rupted by sonication on ice. The bacterial lysates were then centrifuged
at 10,000 3 g for 30 min at 4 °C. The aB-crystallin and aBg, which were
primarily soluble, were purified by gel filtration and ion exchange
chromatography. The sequences of aB-crystallin and aBg were con-
firmed by sequencing the plasmids used for the expression and by mass
spectral fingerprinting of the expressed proteins. The sequences of the
recombinant proteins were identical to those of the proteins in the
cataractous lenses with the exception that the recombinant proteins
were not acetylated on the N termini.
Isolation of Genomic DNA, aB-crystallin Exon 3 Amplification, and
Sequencing—Genomic DNAs were isolated from small pieces of lens
tissue (5–10 mg) by a rapid desalting process using a DNA purification
kit (Epicentre Technologies) and following the recommendations of the
manufacturer. These DNAs (200 ng) served as templates for PCR am-
plification of exon 3 and flanking regions of human aB-crystallin gene
(nucleotide identifier (NID) g181075). Primers were 24-mers in length
and localized at positions 3722 (upper) and 4172 (lower). PCR cycling
conditions were 40 cycles of 94 °C for 5 s, 50 °C for 30 s, and 72 °C for
1 min, using Pfu polymerase (Promega). PCR products were sequenced
by the BigDye Terminator method (PE Applied Biosystems) using the
same primers.
Chaperone-like Activity—Chaperone-like activity was measured as
the ability to protect against the DTT-induced aggregation of lactalbu-
min (30). The reaction was done at 23 °C in 50 mM sodium phosphate
buffer, pH 6.9, containing 0.1 M NaCl and 2 mM EDTA. Lactalbumin
was at 1 mg/ml, and crystallin was at 0.2, 0.5, and 1 mg/ml. Turbidity
was measured at 360 nm.
RESULTS
Two unique protein spots were striking on two-dimensional
electrophoresis gels of the cortical fiber cell protein from some
human cataractous lenses (Fig. 1A). The positions of these
proteins are indicated in Fig. 1A. The spot indicated by the
thick black arrow migrated at a position one charge more acidic
than aB-crystallin and at a Mr of 22,400 which is approxi-
mately 600 less than aB-crystallin (Fig. 1A). The second spot,
indicated by the white arrow migrated at a Mr of 16,400. Both
of these proteins reacted with antibodies made against recom-
binant human aB-crystallin (Fig. 1B) suggesting that the pro-
teins were related to aB-crystallin. Data that will subsequently
be presented in this report show that the Mr 22,400 protein is
a modified form of aB-crystallin. To simplify discussion, this
protein will henceforth be referred to as aBg. Neither aBg nor
the 16.4-kDa protein has been observed on two-dimensional
gels of total fiber cell protein from any normal lens examined
(Fig. 2 (a—c)) or in all cataracts. The cataracts shown in Fig. 2
(d—f) that contain aBg were not clinically classified before
extraction but were determined to be mixed cataracts by visual
examination after intracapsular extraction. The concentration
1 The abbreviations used are: DTT, dithiothreitol; PCR, polymerase
chain reaction; MALDI-TOF, matrix-assisted laser desorption ioniza-
tion-time of flight; PAGE, polyacrylamide gel electrophoresis; HPLC,
high pressure liquid chromatography.
FIG. 1. Two-dimensional gel electrophoresis of a cataractous
human lenses. A portion of the two-dimensional gel protein pattern of
cortical fiber cell protein was Coomassie stained (A) and immuno-
stained (B) with antibodies against recombinant human aB-crystallin
(a gift of Dr. J. Horwitz, UCLA). aBg, thick black arrow; typical form of
aB, white arrowhead; 16.4-kDa fragment, thick white arrow; phospho-
rylated aBg, thin black arrow; and, typical form of aA-crystallin, black
arrowhead.
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of aBg varied from 10 to 90% of the total aB-crystallin (aBg plus
aB-crystallin) in those cataracts in which it was present. In
addition, the total content of aB-crystallin (aBg plus aB-crys-
tallin) was significantly increased in most of these cataracts.
Representative data on three cataracts that contain high con-
centrations of aBg are shown in Table I. Up to 5 times the
normal amount of aB-crystallin was seen. This was determined
by calculating the ratio of aB-crystallin to aA-crystallin. The
amount of aA-crystallin in these cataracts was present at nor-
mal concentrations relative to b-crystallins. To our knowledge,
an increase in the concentration of aB-crystallin in lenses has
not been previously reported.
a-Crystallins are phosphorylated in vivo; however, in the
lens the function of the phosphorylation is not known. As can
be seen in Fig. 1A (thin black arrow), aBg was the only form of
aB-crystallin for which a phosphorylated species was obvious;
phosphorylated species of the typical form of aB-crystallin were
not observed. Three phosphorylation sites have been identified
for aB-crystallin, Ser19, Ser45, and Ser59. Mass spectral data
indicated the presence of a phosphate in the peptide corre-
sponding to residues 2–24 in aBg.
Characterization of aBg—The HPLC chromatograms of the
tryptic digests of aBg and aB-crystallin from cataracts of two
different individuals are presented in Fig. 3. There were no
consistent differences between the chromatograms of aBg and
aB-crystallin that were common to the respective samples from
both individuals. Edman sequencing of several tryptic peptides
of aBg was performed. For each peptide sequenced there was
100% agreement with the sequence of human aB-crystallin
(data not shown). These results confirm that the protein is an
aB-crystallin, albeit, based on the electrophoretic migration, a
modified form of aB-crystallin. Direct Edman sequencing of
aBg, electroblotted onto polyvinylidene difluoride, gave no se-
quence, suggesting that the N terminus of the protein was
blocked. In all aBg samples, a peptide eluting at 40 min corre-
sponded to the C-terminal residues 164–174. Edman sequenc-
ing verified the identity of the peptide and the mass of the
peptide agreed with its theoretical mass. The presence of C-
terminal Lys175 in aBg, however, could not be verified by this
experiment because trypsin would cleave between Lys174 and
Lys175.
Mass fingerprinting was done on trypsin and Asp-N protein
digests of aB-crystallin and aBg using MALDI-TOF mass spec-
trometry. The results are illustrated in Tables II and III. In
Table II, the protonated molecular weights for those peptides
derived by trypsin digestion of aB-crystallin and aBg, as well as
the theoretical protonated molecular weights, are listed. The
presence of peptides with m/z values of 1430.7 and 1431.0 in
the tryptic digests of aBg from both samples indicate that the N
terminus is present and acetylated. In the trypsin digests there
were a few masses that could not be assigned, but there were no
masses consistently present in aBg that were missing in aB-
crystallin or vice versa.
In Table III, the masses for the peptides derived by Asp-N
endoproteinase digestion are listed. aB-crystallin samples con-
tained peptides with m/z 3842.9 and 3842.0. These molecular
weights are consistent with the C-terminal peptide, residues
140–175, that has a theoretical m/z value of 3842.4. A mass
that corresponded to this peptide was absent in both aBg sam-
ples, but in both cataracts aBg contained a peptide absent in
either aB-crystallin spot, with m/z values of 3715.0 and 3714.4
(Fig. 4). These masses are consistent with the theoretical m/z
value of the C-terminal peptide minus Lys175, 3714.3. Asp-N
endoproteinase does not remove Lys175; therefore, the digest
product of residues 140–174 from aBg confirms that Lys
175 is
not present on aBg. In the Asp-N digests there were very few
masses that could not be assigned, and other than the differ-
ences just discussed there were no other peptide masses that
were present in aBg that were missing in aB or vice versa. Only
one peak corresponding to residues 129–139 (DPLTITSSLSS)
was consistently absent in Asp-N spectra, and it was not pres-
ent in either crystallin. In cataract B, there was evidence for
Met68 being present as methionine sulfoxide in both aB-crys-
tallin and aBg. The m/z value of 1294.9 is consistent with the
expected molecular weight of residues 62–72 plus a mass of 16
mass units. The theoretical m/z value of the same peptide with
Met68 oxidized is 1294.61. Between the two enzymatic diges-
tions spectra were obtained for peptides that covered 100% of
the polypeptide sequence. The regions of the polypeptide that
could not be accounted for by tryptic peptides were accounted
for with the peptides from Asp-N digests and the reverse was
also true, making it possible to detect a difference in any
residue of aB-crystallin and aBg. There were no unique modi-
fications, amino acid substitutions, or internal deletions de-
tected in aBg. The excellent agreement of the masses obtained
on the peptide digests of aBg with the respective theoretical
masses of the same peptides in aB-crystallin indicate that
there is only one difference between aBg and aB-crystallin. The
terminal Lys175 is missing in aBg.
The loss of the C-terminal lysine could readily explain the
migration of aBg on two-dimensional gel electrophoresis at a
position 1 charge more acidic than the typical form of aB-
crystallin. However, it did not seem likely that the loss of one
lysine (128 mass units) could explain the migration of aBg at
the lower molecular weight. The only reasonable explanations
were that aBg had region(s) of structure different from aB-
crystallin that remained throughout the electrophoresis even
in the presence of 9 M urea, 2% Nonidet P-40 or 1% SDS and
affected its electrophoretic migration, or that an adduct was
lost during the subsequent analyses.
Recombinant Human aB-crystallin and aBg—To test
whether the removal of the C-terminal lysine was sufficient to
induce the altered migration on electrophoresis as was ob-
served in the second dimension of two-dimensional electro-
FIG. 2. Composite of the aB-crystallin and aBg from two-di-
mensional electrophoresis gels of cataracts and normal human
lenses. Indicated is the position of aB-crystallin and aBg. The Coo-
massie-stained gels were scanned and these spots quantified to deter-
mine the ratios of the species of aB-crystallins present in these cata-
racts. Normal lenses: a, 57 years; b, 17 years; and c, newborn. Cataracts
with aBg: d, e, and f, each were 60–70 years.
TABLE I
Ratio of aB/aA-crystallin
Cataracts are from donors between 60 and 70 years of age.
Lenses aB/aA
Normal 0.3–0.5
Cataract A 1.5
Cataract B 0.6
Cataract C 0.9
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phoresis, both human aB-crystallin and human aB-crystallin
minus the C-terminal lysine (aBg) were cloned and expressed
in E. coli. Both were expressed as soluble proteins in this
system. Neither protein was acetylated on the N-terminal me-
thionine. The recombinant human aB-crystallin and the recom-
binant human aBg eluted from a Superose 6 gel filtration
column as aggregates with apparent molecular weights of
570,000 and 510,000, respectively (Fig. 5). Significantly
smaller species were also observed for aBg (data not shown). As
shown in Fig. 6A, even after boiling in SDS, the recombinant
aBg migrated slightly faster than recombinant aB-crystallin on
SDS-PAGE. The calculated difference in the molecular weight
between the recombinant aB-crystallin and recombinant aBg
was approximately 700, similar to the difference observed on
FIG. 3. HPLC chromatograms of
tryptic digests of aB-crystallin and
aBg from two cataracts. Reverse phase
HPLC of native aB-crystallin and aBg.
Tryptic peptides were monitored at A205.
TABLE II
aB-Crystallin tryptic digest products determined by MALDI-TOF
mass spectrometry
Residues Theoreticalm/za
Cataract A Cataract B
aB aBg aB aBg
1–11/Ac 1430.7 1430.9 1430.7 1431.0
12–22 1374.7 1374.8 1374.8 1374.9 1374.9
23–56 4006.5 4006.7
57–69 1496.7 1496.9 1496.9 1497.0
75–82 921.5 921.5 921.5 921.7
83–92 1213.7 1213.8 1213.6 1213.8 1213.9
93–116 2788.1 2787.8 2787.8 2787.9 2787.0
117–120 588.3 588.3 588.3 588.3 588.4
121–149b 3073.5 3073.2 3074.2 3073.6 3073.9
150–157 900.5 900.6 900.6 900.7
158–174 1822.0 1822.0 1822.5 1822.4 1822.4
a Theoretical monoisotopic m/z values are listed for m/z less than
2000, and theoretical average m/z values are listed for m/z greater than
2000.
b The identical mass also corresponds to residues 122–150.
TABLE III
aB-crystallin Asp-N endoproteinase digest products determined by
MALDI-TOF mass spectrometry
Residues Theoreticalm/za
Cataract A Cataract B
aB aBg aB aBg
2–24 2875.4 2875.1 2875.5 2875.1 2875.5
25–35 1321.6 1321.8 1321.8 1321.8 1321.8
36–61 3031.5 3031.1 3031.5 3031.2 3031.0
62–72 1278.6 1278.8 1278.8
62–72/msob 1294.9 1294.8 1294.8
73–79 850.4 850.5 850.5 850.5 850.6
80–95 1825.0 1826.3 1826.3 1826.3 1825.3
96–108 1575.8 1576.0 1576.0 1576.0 1576.0
109–126 2259.5 2259.6 2259.5 2259.7 2259.5
129–139 1121.2
140–175 3842.4 3842.0 3842.9
140–174 3714.3 3715.0 3714.4
aB PAVTAAPKK175
aBg PAVTAAPK174
a Theoretical monoisotopic m/z values are listed for m/z less than
2000, and theoretical average m/z values are listed for m/z greater than
2000.
b The expected mass for peptide 62–72 upon oxidation of Met68.
FIG. 4. Mass spectra of C-terminal, Asp-N endoproteinase di-
gest peptides of native aB-crystallin and aBg. Protein spots of
aB-crystallin and aBg were cut out of a two-dimensional gel and sub-
jected to in-gel digestion by Asp-N endoproteinase. Resultant peptides
were extracted and analyzed by MALDI-TOF mass spectrometry. The
portions of the spectra showing the difference between aB-crystallin
and aBg are shown. The m/z value of 3842.9 corresponds to the singly
charged peptide of residues 140–175, which has a theoretical average
m/z of 3842.4. The m/z 3714.4 corresponds to the singly charged peptide
of residues 140–174, which has a theoretical average m/z of 3714.3. The
absence of a peak at m/z 3842.4 and the coincident mass at m/z 3714.4
in the spectrum of aBg indicates that Lys
175 is not present in aBg.
Modified aB-crystallin in Cataract32290
 by guest, on April 14, 2011
w
w
w
.jbc.org
D
ow
nloaded from
 
two-dimensional gels of lens proteins. These results show that
the removal of the C-terminal lysine is sufficient to cause the
migration of aBg at a significantly lower molecular weight than
aB-crystallin. The pI values determined by isoelectric focusing
under non-denaturing conditions for both proteins are shown in
Fig. 6B. The recombinant aB-crystallin had a native pI of 6.8,
and recombinant aBg had a native pI of 5.8. The theoretical pI
values are 6.76 and 6.50, respectively.
Chaperone-like Activity—a-Crystallins exhibit a chaperone-
like activity, protecting against aggregation of proteins that is
induced by heat, oxidation, and reduction by DTT (30). The
effect of the removal of the C-terminal lysine on the chaperone-
like activity of aB-crystallin was assessed by determining the
ability of the recombinant forms of human aB-crystallin and
aBg to prevent the DTT-induced aggregation of lactalbumin. As
shown in Fig. 7, the removal of the C-terminal lysine had
essentially no effect on the chaperone-like activity of this pro-
tein under these conditions.
16.4-kDa Protein—The 16.4-kDa protein was present at a
concentration about one-tenth that of aBg and has only been
observed in samples that contain aBg. Direct Edman sequenc-
ing was performed on the 16.4-kDa protein from cataracts of
two different individuals. These data are shown in Fig. 8. The
16.4-kDa protein in lens 1 yielded multiple N-terminal se-
quences, Ser43, Ser41, Ser45, and Phe47. All sequences were
identical to aB-crystallin. MALDI-TOF derived data on the
16.4-kDa protein from a third individual indicated the N ter-
mini were Ser43 and Ser41. In a fourth individual the N termi-
nus was Pro39 (Table IV). Two of the cleavages were between
Thr and Ser, one between Leu and Ser, one between Pro and
Phe, and the fourth was between Phe and Pro. The significance
of these data is that multiple N termini have been identified,
each different by two or multiples of two residues.
Tryptic digests of this spot were similar but not identical to
that of aB-crystallin. A peptide with a mass of 1140 Da that
FIG. 5. Oligomeric sizes of recombinant human aB crystallin
and aBg. Recombinant human aB-crystallin and aBg were purified by
gel filtration and ion exchange chromatography. The figure is an over-
lay of the final purification chromatograms of both recombinant pro-
teins from a Superose 6 HR 10/30 gel filtration column. Recombinant
human aB-crystallin peak (solid line) eluted at ;570 kDa (90% of the
peak area was in the range of 270–970 kDa) and recombinant human
aBg peak (dotted line) eluted at ;510 kDa (90% of the peak area was in
the range of 260–940 kDa). The column was calibrated immediately
before purification of both recombinants using thyroglobulin (669 kDa),
b-amylase (200 kDa), bovine serum albumin (66 kDa), and carbonic
anhydrase (30 kDa) (inset).
FIG. 6. SDS-PAGE and native isoelectric focusing of recombi-
nant human aB-crystallin and aBg. The relative sizes of the sub-
units of purified rhaB-crystallin and rhaBg were calculated from their
migration on 14% polyacrylamide gels. The relative isoelectric points of
the two recombinants were calculated from their migration under na-
tive conditions on 5% polyacrylamide isoelectric focusing gel. SDS-
PAGE: lanes 1 and 6, molecular weight markers; lanes 2 and 3, rhaB-
crystallin (21.5 kDa); lanes 4 and 5, rhaBg (20.7 kDa). Native isoelectric
focusing: lanes 1 and 6, isoelectric point markers; lanes 2 and 3, rhaB-
crystallin (pI 6.8); lanes 4 and 5, rhaBg (pI 5.8).
FIG. 7. Chaperone-like activity of recombinant human aB-
crystallin and aBg. The incubation mixture contained 50 mM sodium
phosphate, 0.1 M NaCl, 2 mM EDTA, pH 6.9, 50 mM DTT, and 1 mg/ml
a-lactalbumin, in the absence (l) and presence of rhaB-crystallin, 1
mg/ml (f), 0.5 mg/ml (), and 0.2 mg/ml (1) (A); 1 mg/ml a-lactalbumin
in the absence (l) and presence of rhaBg 1 mg/ml (M), 0.5 mg/ml (),
and 0.2 mg/ml (3) (B).
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eluted at the same time as a peptide identified by sequencing as
residues 164–174 was present. MALDI-TOF mass spectral
analysis of Asp-N endoproteinase digests showed the absence
of a peak at m/z 3842.4 which would correspond to residues
140–175 of aB-crystallin (Table IV). There was, however, a
peak at m/z 3714.5 which corresponds to residues 140–174. As
shown in Table IV, experimental m/z values were matched to
theoretical m/z values from Asp-N cleavage that covered most
of the polypeptide. Aside from the N-terminal peptides, the
only mass missing was the same one not observed in aB and
aBg. A unique peak at m/z 3130.5 was observed. This mass may
correspond to residues 39–66 (3129.8). These results show that
the 16.4-kDa protein is derived from aBg.
Genomic Analysis—The mechanism by which aBg is gener-
ated in these cataractous lenses is not known. One possibility
was that aBg is the product of a mutated gene for aB-crystallin
since a single nucleotide change could convert the codon for
lysine to a stop codon. To test this possibility PCR products
were obtained for the last exon of the aB-crystallin gene using
genomic DNA prepared from lenses containing aBg. The se-
quences of the PCR products indicated that there was no mu-
tation in the gene for aB-crystallin (data not shown).
DISCUSSION
We have demonstrated that in some human cataracts the
concentration of the small heat shock protein, aB-crystallin, is
significantly increased. This could be the result of an up-regu-
lation of its expression and/or a diminution of its degradation in
the lens. Regardless, it represents a significant deviation from
the normal protein composition of the lens and is the first time
such an observation has been made in a human cataract. We
have also provided evidence for aberrant N- and C-terminal
processing of aB-crystallin. One atypical form of aB-crystallin
found in high concentrations in these cataracts has been des-
ignated aBg. This species is aB-crystallin minus the C-terminal
lysine. A second atypical form of aB-crystallin, found at about
10% the concentration of aBg, is a 16.4-kDa fragment of aBg. In
this protein 38–46 N-terminal residues have also been removed.
The removal of the C-terminal lysine does not diminish the
chaperone-like activity of aB-crystallin under the conditions
used for these studies. As reported here (Fig. 7) the chaperone-
like activity of the recombinant human aBg is comparable to
that of the recombinant human aB-crystallin in protecting
against the DTT-induced aggregation of lactalbumin at room
temperature. aA- and aB-crystallin have polar, flexible C-ter-
minal extensions that are thought to contribute to the solubil-
ity of these crystallins and have been implicated in their chap-
erone-like activity (31). Substitution of Lys174-Lys175 of aB-
crystallin with Leu-Leu significantly diminished chaperone-
like activity; however, removal of the last 5 residues had little
effect on chaperone-like activity (32). Likewise, in aA-crystallin
the introduction of tryptophan at the C terminus and removal
of 17 C-terminal residues diminished chaperone activity (33–35).
Maintenance of a polar, flexible C-terminal extension appears to
be an important factor for maintaining chaperone-like activity
(33). Thus, it is not surprising that aBg has full activity in
protecting against the DTT-induced aggregation of lactalbumin.
The only modification identified for aBg was the loss of
Lys175. There was nothing in the mass spectral, HPLC, and
protein sequence data that suggested an additional modifica-
tion. The N and C termini of the protein were otherwise intact.
The N-terminal methionine was acetylated, and every peptide
sequence examined matched aB-crystallin exactly. With the
exception of the mass corresponding to the loss of the C-termi-
nal lysine, there were no masses found by MALDI-TOF mass
spectrometry that were consistently present in aBg that were
not present in aB-crystallin from the same cataract and vice
versa. This held for both Asp-N and trypsin digests of the
proteins, and, combining data from both digests, the entire
sequences of both aBg and aB-crystallin were analyzed. These
data rule out splice variants and other mutations unless re-
placements have the same mass and would not be detected in
the MALDI-TOF mass spectrometry fingerprint analysis.
It was confirmed that the removal of the carboxyl-terminal
lysine (128.09 mass units) was responsible for the faster mi-
gration of aBg on SDS-PAGE relative to aB-crystallin. This was
demonstrated using the recombinant forms of these proteins.
In addition to showing that a difference of one lysine was
sufficient to alter the migration on SDS-PAGE, it also sup-
ported the conclusion that the only modification of aBg was the
lack of the terminal lysine. Smulders et al. (33) demonstrated
that a mutant of aA-crystallin with an extension of ALRKG
migrated on SDS-PAGE slightly slower than mutants with
ALGKG or ALDKG. Thus, addition of one more positive charge
in the C-terminal extension of either aA- or aB-crystallin can
slightly retard its electrophoretic mobility.
In this study, aBg and the 16.4-kDa proteins were only
observed in cataracts but not in all human cataracts. Over 70
cataracts from 60 to 90 years have been analyzed. Eight cata-
racts have the high concentration of aBg. Many other cataracts
have aBg but at lower concentrations. So far, a correlation
cannot be made between the presence of these proteins in
cataracts and any cataract etiology. Neither aBg nor the 16.4-
kDa fragment have been observed in our laboratory on two-
dimensional electrophoresis of normal human lens total pro-
tein, water-soluble or water-insoluble fractions, of about 50
non-cataractous lenses (newborn to 75 years). However, the
presence in a normal lenses of a low concentration of an a-crys-
tallin with a mass that corresponded to aB-crystallin minus the
C-terminal lysine has been reported using liquid chromatogra-
phy/mass spectrometry (36–38). The sensitivity of electrospray
FIG. 8. N-terminal sequences of aB-crystallin 16-kDa frag-
ments. N-terminal sequences of the 16.4 kDa are compared with the
aB-crystallin sequence. Sequencing was performed by Harvard Micro-
Chem. Underlined residues are lower confidence. For lens 1, determi-
nation of the predominance of sequences was done by Harvard Micro-
chem using the relative concentrations of amino acids in each cycle and
the typical yields of each amino acid.
TABLE IV
16.4-kDa protein Asp-N digest products determined by MALDI-TOF
mass spectrometry
Residuesa Theoreticalm/zb
Measured 16.4
kDa
39–66 3129.8 3130.5
62–72 1278.6 1278.7
73–79 850.4 850.4
80–95 1825.0 1825.2
96–108 1575.8 1575.9
109–126 2259.5 2259.4
127–139
140–174 3714.3 3714.5
a Residue numbers correspond to those of aB-crystallin.
b Theoretical monoisotopic m/z values are listed for m/z less than
2000, and theoretical average m/z values are listed for m/z greater than
2000.
Modified aB-crystallin in Cataract32292
 by guest, on April 14, 2011
w
w
w
.jbc.org
D
ow
nloaded from
 
ionization mass spectrometry made the detection of very low
levels of aBg in non-cataractous lenses possible, whereas Fig. 2
clearly shows that aBg is not detected by Coomassie Blue
staining of normal lens proteins. The findings in other labora-
tories suggest that at least very low concentrations of aBg may
exist in normal lenses and that aBg and possibly the 16.4-kDa
fragment may be intermediates in the normal pathway of proc-
essing aB-crystallin (36–38). In the cataracts examined in this
study, there may be increases and/or decreases in proteinases
that result in the accumulation of these species. Interestingly,
aA-crystallin which has Ser-Ser as the final C-terminal resi-
dues is found with only the final Ser removed (60). This form of
aA-crystallin has been observed in normal human and bovine
lenses. The functional significance of the modified form is not
known. Furthermore, the significance of the processing of
a-crystallins to cataractogenesis is not known.
Multiple proteinases are certain to be involved in the post-
translational modification of aB-crystallin generating aBg and
the 16.4-kDa fragment. The data reported in this study rule out
the possibility that aBg is the result of a mutation in the
aB-crystallin gene but cannot rule out a genetic component
involving other genes such as proteinases or involving the
regulation of proteinases. There was a high incidence of aBg in
cataracts from India. This supports the possibility of a genetic
component. Alternatively, the high incidence in cataracts from
India could indicate the presence of a particular form of stress
on the lens which alters the proteinase activities.
In aBg the terminal lysine is removed but not the penulti-
mate lysine. The first cleavage would be a Lys-Lys cleavage
and the second a Pro-Lys cleavage. Carboxypeptidases have
been described that are specific for basic amino acids for which
the penultimate amino acid alters the rate of cleavage (39).
Peptide carboxypeptidases have been described that will not
cleave prolysyl bonds, and endopeptidases with specificity for
pairs of basic amino acids that will remove one or both of the
basic residues have been described (39). Thus, the specificity
for removing one but not both lysine residues is possible; how-
ever, whether any of these proteinases are in the lens is not
known. If the removal of the C-terminal lysine is related to
function, it is possible a specific carboxypeptidase may be in-
duced during stress.
The 16.4-kDa protein is an N-terminally truncated form of
aBg and was only observed in those lenses in which aBg was in
high concentration. Multiple N termini were identified, but the
major N terminus was Ser43. Since each N terminus repre-
sented the removal of two residues or multiples of two, it is
reasonable to suggest that cleavage is catalyzed by a dipeptidyl
peptidase. Dipeptidyl peptidases II (lysosomal) and III (cyto-
plasmic) are present in lens and cataracts (40, 41). However,
both of these preferentially use peptides as substrates, not
proteins. Dipeptidyl peptidases that utilize proteins as sub-
strates exist but, to our knowledge, have not been described in
the lens. The N termini of aBg and aB-crystallin are blocked, so
presumably a different proteinase made the first cleavage.
Acylaminohydrolases that could cleave the acetylmethionine
are present in lenses (42).
Our hypothesis is that a stress mechanism is involved in
generating both the high concentrations of aB-crystallin and
the subsequently modified forms, aBg and the 16.4-kDa pro-
tein, and that the increased concentration of aB-crystallin is an
effort by the lens to protect against loss of lens function. That
a stress mechanism is involved is strongly supported by our
observation that aBg was present in the lens from an infant
with microphthalmia, coloboma, and persistent hyperplastic
primary vitreous.2 The latter is a condition where the vessels
do not regress at the appropriate time in development and cells
invade the back of the lens. Our assumption is that this is
perceived by the lens as an extreme stress condition. In addi-
tion, two forms of aB-crystallin were induced in hypertonically
stressed dog lens epithelial cells in culture (21). Direct evidence
is not yet available, but it is highly likely, based on the migra-
tion on two-dimensional gels, that the atypical form of aB-
crystallin found is aBg. aB-crystallin is a member of the family
of small heat shock proteins and in cultured cells, including
lens cells, aB-crystallin is induced by heat shock, oxidative
stress, osmotic stress, sodium arsenite, phorbol 12-myristate
13-acetate, and hormones such as estrogen and dexamethasone
(20–23, 43, 44). Heat shock proteins are also phosphorylated in
response to stress (45). a-Crystallins are phosphorylated in
vivo and in vitro (46–48). The role of phosphorylation of aB-
crystallin in lens is not understood, but aBg was preferentially
phosphorylated in the cataracts examined.
This is the first time an increased concentration of aB-crys-
tallin has been described in vivo in human lenses. The in-
creased concentration is due to the presence of aBg not to an
increased concentration of the typical form of aB-crystallin.
Due to the nature of the lenses, it is difficult to determine
whether there is truly an increased expression or a decreased
degradation of aB-crystallin. If the increased concentration of
aB-crystallin reflects diminished processing, the degradation of
this protein must occur at a much greater rate in human lens
than previously appreciated. We propose that there is an in-
creased expression due to chronic stress conditions and altered
processing of aB-crystallin generating aBg in these cataracts.
aB-crystallin also accumulates in brains of individuals with
neurological disorders (49–51). It is unclear in these cases, as
well as the cataracts, whether the presence of aB-crystallin is
an attempt to rescue the tissue or if it is a contributor to the
pathology. We think it is unlikely that the increased concen-
tration of aB-crystallin and the presence of the modified forms
cause the loss of lens clarity in the cataracts, but it must be
considered.
The functional significance of the post-translational modifi-
cation of aB-crystallin described here is not known. In the
intact lens, it is unclear whether the primary function of aB-
crystallin is that of a stress protein and related to its chaper-
one-like activity or if it is structural. The findings that aBg is
present in a lens with persistent hyperplastic primary vitreous
and is induced by hypertonic stress in lens cells suggests a
major role is stress-related. Based on a number of reports,
aB-crystallin interacts with actin, intermediate filaments,
membranes, and components in cell nuclei (52–57). Lys175 has
been implicated as an amine donor substrate for transglutami-
nase reactions (58, 59). The data presented suggest aBg has
some difference in structure from the typical form of aB-crys-
tallin. This is likely to alter specific protein-protein interac-
tions. In fact, the larger than expected change in the native pI
of aBg supports the observations that the C-terminal lysine is
involved in intramolecular interactions and is likely to affect
intermolecular interactions as well. Further evidence for this is
the preferential phosphorylation of aBg over aB-crystallin.
Studies in progress will hopefully elucidate the mechanisms
involved in the increased concentration of aB-crystallin and the
function of aBg in lens and in cataracts. They will also deter-
mine whether the pathway for modification of aB-crystallin is
one specific to lens or is a general pathway induced by stress in
other tissues.
2 D. Garland, unpublished data.
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